New technologies as a strategy to decrease medication errors: how do they affect adults and children differently?

Margarita Ruano1, Elena Villamañán2, Ester Pérez2

  • 1Department of Pharmacy, La Paz University Hospital, Madrid, Spain. margarita.ruano@salud.madrid.org.

Insights

New technologies like computerized physician order entry (CPOE) can reduce pediatric medication errors. However, careful implementation is crucial to avoid introducing new risks in child healthcare settings.

Area of Science:

  • Pediatric pharmacology
  • Health informatics
  • Patient safety

Background:

  • Medication errors pose a higher risk of severe adverse effects and injury in children compared to adults.
  • Pediatric medication errors are particularly significant due to children's unique risk factors and physiological differences.
  • Errors commonly occur during the prescribing and administration phases of drug treatment.

Purpose of the Study:

  • To review available data on new technologies aimed at reducing medication errors in pediatric populations.
  • To assess the effectiveness and potential drawbacks of technological interventions in pediatric patient safety.

Main Methods:

  • Literature review of published data on new technologies for reducing pediatric medication errors.
  • Analysis of studies focusing on computerized physician order entry (CPOE) and decision-support platforms.

Main Results:

  • New technologies, particularly CPOE and decision-support systems, have demonstrated effectiveness in reducing medication errors.
  • Despite benefits, the implementation of these informatics tools can introduce novel types of errors.
  • A lack of standardized definitions and terminology complicates comparative analysis across studies.

Conclusions:

  • Prioritizing the implementation of CPOE programs in pediatric care is essential for enhancing patient safety.
  • Improving communication among healthcare professionals involved in the care of hospitalized children is a key priority.
  • Increased knowledge and understanding of these technological programs among healthcare providers are crucial for safe and effective use.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
77
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
347
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
738
Guidelines for Nursing Documentation I01:30

Guidelines for Nursing Documentation I

Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:  
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
2.6K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K